Article
DNA Methylation-Guided Prediction of Clinical Failure in High-Risk Prostate Cancer
18 Jun 2015
Abstract excerpt
BACKGROUND: Prostate cancer (PCa) is a very heterogeneous disease with respect to clinical outcome. This study explored differential DNA methylation in a priori selected genes to diagnose PCa and predict clinical failure (CF) in high-risk patients. METHODS: A quantitative multiplex, methylation-specific PCR assay was developed to assess promoter methylation of the APC, CCND2, GSTP1, PTGS2 and RARB genes in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
